- Investing Ideas
- /
- German Pharmaceuticals & Biotech Consumer Staple Stocks
German Pharmaceuticals & Biotech Consumer Staple Stocks
Results
1412
0 new
Companies in consumer staple industries including durables, food, beverage, tobacco, and household and personal products.
1,412 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$791.00 | -5.6% | 56.9% | US$818.8b | US$897.00 | PE107.6x | E28.5% | 0.6% | ||
LLY | US$786.40 | -5.5% | 54.7% | US$818.8b | US$891.78 | PE107.6x | E28.5% | 0.6% | ||
LLY0 | US$21.00 | -2.8% | n/a | US$818.8b | US$23.81 | PE107.6x | E28.5% | 0.6% | ||
NOV | DKK 108.48 | -5.0% | 24.6% | DKK 3.5t | DKK 129.56 | PE39.3x | E14.4% | 1.2% | ||
NOV | DKK 107.56 | -5.5% | 24.6% | DKK 3.5t | DKK 128.66 | PE39.3x | E14.4% | 1.2% | ||
NOVA | DKK 108.00 | -5.3% | 26.2% | DKK 3.5t | DKK 128.98 | PE39.3x | E14.4% | 1.2% | ||
JNJ | US$145.60 | -1.0% | -1.0% | US$388.5b | US$154.55 | PE23.7x | E7.2% | 3.1% | ||
JNJ | US$146.16 | -1.0% | -1.2% | US$388.5b | US$155.15 | PE23.7x | E7.2% | 3.1% | ||
JNJ0 | US$13.90 | -2.1% | -3.7% | US$388.5b | US$14.75 | PE23.7x | E7.2% | 3.1% | ||
4AB0 | US$17.50 | -0.6% | 17.4% | US$339.0b | US$17.66 | PE64.9x | E25.3% | 3.2% | ||
4AB | US$171.64 | -0.8% | 21.2% | US$339.0b | US$173.19 | PE64.9x | E25.3% | 3.2% | ||
4AB | US$175.04 | 1.0% | 23.0% | US$339.0b | US$176.62 | PE64.9x | E25.3% | 3.2% | ||
6MK | US$101.80 | -3.0% | 4.9% | US$286.7b | US$124.49 | PE21x | E14.4% | 2.7% | ||
6MK | US$102.00 | -3.0% | 4.3% | US$286.7b | US$124.73 | PE21x | E14.4% | 2.7% | ||
RHO6 | CHF 36.47 | 4.7% | 13.9% | CHF 219.0b | CHF 40.34 | PE20.4x | E10.9% | 3.5% | ||
ZEG | UK£139.80 | -1.4% | 7.4% | UK£180.7b | UK£165.65 | PE37.5x | E16.4% | 1.9% | ||
ZEGA | UK£69.50 | -0.7% | 8.6% | UK£180.7b | UK£82.35 | PE37.5x | E16.4% | 1.9% | ||
ZEG | UK£139.85 | -0.6% | 8.5% | UK£180.7b | UK£165.71 | PE37.5x | E16.4% | 1.9% | ||
TN80 | US$14.50 | 0% | n/a | US$236.6b | US$15.29 | PE37.7x | E10.6% | 0.3% | ||
TN8 | US$557.10 | 1.5% | 16.0% | US$236.6b | US$587.33 | PE37.7x | E10.6% | 0.3% | ||
TN8 | US$553.20 | 0.8% | 16.4% | US$236.6b | US$583.22 | PE37.7x | E10.6% | 0.3% | ||
NOTA | CHF 101.50 | -1.9% | 5.1% | CHF 198.3b | CHF 101.67 | PE23.4x | E9.4% | 3.1% | ||
DAP | US$248.45 | 0.4% | 6.0% | US$200.0b | US$259.82 | PE49x | E14.3% | 0.4% | ||
DAP | US$249.30 | 1.9% | 5.8% | US$200.0b | US$260.71 | PE49x | E14.3% | 0.4% |